Michael Halstead
CIK 1521548 · President · last filed 2025-04-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
1
Total Filings
61
Lifetime Open-Market Net
-$33.09M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Intra-Cellular Therapies, Inc. (ITCI) Delisted | President | 0 | $131.87 | $0 | -$33.09M | 43 | 2025-04-02 |
Recent Filings · Page 6 of 7
61 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2013-01-23 | — | Sell (S) | −488 | -$6.6K | |
| 2012-10-01 | — | Sell (S) | −77 | -$1.0K | |
| 2012-07-02 | — | Sell (S) | −355 | -$6.4K | |
| 2012-03-02 | — | Sell (S) | −725 | -$12.3K | |
| 2012-02-23 | — | Sell (S) | −409 | -$6.9K | |
| 2012-02-02 | — | Grant (A) | +20,790 | $0 | |
| 2012-01-31 | — | Sell (S) | −320 | -$5.3K | |
| 2012-01-24 | — | Sell (S) | −487 | -$8.4K | |
| 2012-01-12 | — | Sell (S) | −452 | -$7.5K | |
| 2011-10-03 | — | Sell (S) | −78 | -$1.1K |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.